Pituitary carcinoma is extremely rare and difficult to diagnose early. Here we present a case
of highly suspected pituitary malignant adenoma with early chemotherapy and radiation. A …

Pituitary carcinoma is a rare malignancy and is difficult to manage. Pituitary carcinomas
commonly produce either PRL or ACTH, but some do not produce pituitary hormones. The …

Pituitary carcinomas are a rare disease with an estimated prevalence around 0.2% of the
pituitary tumours. They are defined by the presence of intra or extra-cranial metastases but …

Background Pituitary carcinomas (PC) and atypical pituitary adenomas (APA) are rare
variants of pituitary tumors for which no evidence-based treatment currently exists. We …

Background Treatment of aggressive pituitary adenomas typically involves a multimodality
approach based on histopathological features and may include pharmacotherapy, surgery …

Objective To describe a case of a pure silent somatotroph pituitary carcinoma. Methods We
describe a 54-year-old female with a clinically nonfunctioning pituitary macroadenoma …

Although pituitary adenomas (PAs) account for 15% of intracranial tumors, pituitary
carcinomas (PCs) are a rare entity. Most commonly, PCs evolve from aggressive PAs …

The optimal treatment of pituitary carcinomas (PC) is unknown. Treatment includes surgical
resection, radiation, and more recently, temozolomide (TMZ). Pituitary adenomas have …

Pituitary carcinomas are rare, accounting for about 0· 2% of all pituitary tumours. They
represent a challenge to clinical practice in both diagnosis and treatment. They may present …

Objective Pituitary carcinomas are extremely rare tumors associated with poor prognosis
despite surgery, radiation, and chemotherapy. The hallmark of diagnosis implies …